CompletedNCT02381457
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Studying OBSOLETE: Anomaly of chromosome 22
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Natera, Inc.
- Principal Investigator
- Peer Dar, MDMontefiore Medical Center
- Enrollment
- 20960 enrolled
- Eligibility
- 18-48 years · FEMALE
- Timeline
- 2015 – 2020
Study locations (21)
- University of California, San Francisco, San Francisco, California, United States
- Cooper University Hospital, Camden, New Jersey, United States
- Virtua, Mount Laurel, New Jersey, United States
- St. Peter's University, New Brunswick, New Jersey, United States
- Complete Women's Healthcare, Garden City, New York, United States
- North Shore University Hospital, Manhasset, New York, United States
- Madonna Perinatal, Mineola, New York, United States
- Long Island Jewish Medical Center, New Hyde Park, New York, United States
- New York University, New York, New York, United States
- Icahn School of Medicine Mt Sinai, New York, New York, United States
- Columbia University, New York, New York, United States
- Montefiore Medical Center, New York, New York, United States
- Suffolk OB, Port Jefferson, New York, United States
- North Austin Maternal Fetal Medicine, Austin, Texas, United States
- Zeid Women's Health Center, Longview, Texas, United States
- +6 more locations on ClinicalTrials.gov
Collaborators
George Washington University · University of California, San Francisco · Montefiore Medical Center · Children's Hospital of Philadelphia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02381457 on ClinicalTrials.gov